Position in EXEL
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$18,335
+$15,162 QoQ
Shares Held
337
+355.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#650
of 751 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sachetta, LLC holds $96,277 across 19 Biotechnology names. EXEL ranks #1 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
This page
|
337 | $18,335 | |
| 2 | MRNA |
Moderna, Inc.
|
217 | $15,196 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
60 | $14,457 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
159 | $6,202 | |
| 5 | RPRX |
Royalty Pharma plc
|
109 | $6,111 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
105 | $5,726 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
143 | $5,060 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
27 | $5,056 |
All Filings in EXEL
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,335 | 337 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $3,173 | 74 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $4,777 | 109 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $4,501 | 109 | Shares | Defined | 2025-10-24 | |
| 2025-06-30 | $4,804 | 109 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $2,732 | 74 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $2,464 | 74 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $1,920 | 74 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $1,662 | 74 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $1,756 | 74 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $1,775 | 74 | Shares | Defined | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||